Invention Grant
- Patent Title: Triazolopyridine compounds as PIM kinase inhibitors
- Patent Title (中): 三唑并吡啶化合物作为PIM激酶抑制剂
-
Application No.: US14001657Application Date: 2012-02-24
-
Publication No.: US08889704B2Publication Date: 2014-11-18
- Inventor: James F. Blake , Robert Kirk Delisle , Lisa A. De Meese , James M. Graham , Yvan Le Huerou , Michael Lyon , John E. Robinson , Eli M. Wallace , Bin Wang , Rui Xu
- Applicant: James F. Blake , Robert Kirk Delisle , Lisa A. De Meese , James M. Graham , Yvan Le Huerou , Michael Lyon , John E. Robinson , Eli M. Wallace , Bin Wang , Rui Xu
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris & Padys PLLP
- Agent Sarah S. Mastous
- International Application: PCT/US2012/026572 WO 20120224
- International Announcement: WO2012/154274 WO 20121115
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D487/10 ; C07D491/048 ; C07D401/06 ; C07D519/00
Abstract:
Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
Public/Granted literature
- US20140005213A1 TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS Public/Granted day:2014-01-02
Information query
